Fort de son expertise le CIR3 publie de nombreuses revues scientifiques sur son domaine, les publications pour chaque année du CIR 3 :
 
Pour 2022 :

Giron M., Thomas M., Dardevet D., Chassard C., Savary-Auzeloux I. Gut microbes and muscle
function: can probiotics make our muscles stronger?. Journal of Cachexia, Sarcopenia and
Muscle, 2022, 13 (3), 1460-1476, 10.1002/jcsm.12964, https://hal.inrae.fr/hal-03642370. IF:
9,95

Thivel D, Corteval A, Favreau JM, Bergeret E, Samalin L, Costes F, Toumani F, Dualé C, Pereira
B, Eschalier A, Fearnbach N, Duclos M, Tournadre A. Fine Detection of Human Motion During
Activities of Daily Living as a Clinical Indicator for the Detection and Early Treatment of
Chronic Diseases: The E-Mob Project. J Med Internet Res. 2022 Jan 14;24(1):e32362. doi:
10.2196/32362. PMID: 35029537; PMCID: PMC8800083. IF: 7,51

Descheemaeker A, Poras H, Wurm M, Luccarini P, Ouimet T, Dallel R. Dual enkephalinase
inhibitor PL37 as a potential novel treatment of migraine: evidence from a rat model. Brain.
2022 Aug 27;145(8):2664-2670. doi: 10.1093/brain/awac139. PMID: 35411377. IF: 8,69

L. Sauzeat, J. Eychenne, L. Gurioli, M. Boyet, D. Jessop, R. Moretti, M. Monrose, H. Holota, C.
Beaudoin and D. Volle, “Metallome deregulation and health-related impacts due to long-
term exposure to recent volcanic ash deposits: New chemical and isotopic insights.”, The
Science of the total environment, pp. 154383, 2022. IF: 10,14

N. Allegre, S. Chauveau, C. Dennis, Y. Renaud, D. Meistermann, L. Estrella, P. Pouchin, M.
Cohen-Tannoudji, L. David and C. Chazaud, “NANOG initiates epiblast fate through the
coordination of pluripotency genes expression.”, Nature communications, vol. 13 (1) , pp.
3550, 2022. IF: 15,40

E Thivat , M Chanchou, S Mathieu, S Levesque, T Billoux, P Auzeloux , N Sas, I Molnar, E
Jouberton, J Rouanet, G Fois , L Maigne , MJ Galmier, F Penault-Llorca , E Miot-Noirault , X
Durando and F Cachin. Assessment of 99mT-NTP 15-5 uptake on cartilage, a new
proteoglycan tracer: study protocol for a phase I trial (CARSPECT). Front Med (Lausanne)
2022, 9, 993151. https://doi.org/10.3389/fmed.2022.993151. IF : 10,92

Pour 2023 :

Thivel D, Ennequin G, Lambert C, Siroux J, Ratel S, Boscaro A, Plissier L, Julian V, Cardenoux C,
Duclos M, Lazzer S, Pereira B, Boirie Y, Isacco L. Improved walking energy efficiency might
persist in presence of simulated full weight regain after multidisciplinary weight loss in
adolescents with obesity: The POWELL study. International Journal of Obesity (2023).
https://doi.org/10.1038/s41366-023-01427-w IF 4.9

Souidi A, Nakamori M, Zmojdzian M, Jagla T, Renaud Y, Jagla K. Deregulations
of miR-1 and its target Multiplexin promote dilated cardiomyopathy associated
with myotonic dystrophy type 1. EMBO Rep. 2023 Apr 5;24(4):e56616 IF 9.1

Pickering ME, Javier RM, Malochet S, Pickering G, Desmeules J. Osteoporosis treatment and
pain relief: A scoping review. Eur J Pain. 2024 Jan;28(1):3-20. doi: 10.1002/ejp.2156. IF 3.6

Pour 2024 :

Bailly M, Beraud D, Lambert C, Garnier YM, Pereira B, Duclos M, Boirie Y, Isacco L, Thivel D, Verney J. Constitutional thinness might be characterized by physiologically adapted and not impaired muscle function and architecture: new results from the NUTRILEAN study. Eur J Appl Physiol. 2024 Nov;124(11):3303-3315. IF 3,03

Boscaro A, Bailly M, Pereira B, Beraud D, Costes F, Julian V, Duclos M, Finlayson G, Thivel D, Boirie Y, Verney J. Post-exercise energy replacement might lead to reduced subsequent energy intake in women with constitutional thinness: Exploratory results from the NUTRILEAN project. Appetite. 2024 Apr 1;195:107203.  IF 5,25

T. FRAZIER, E. PEREIRA, R. AESOY, L. NAUTON, F. GIRAUD, L. HERFINDAL, F. ANIZON, P. MOREAU
Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles.
European Journal of Medicinal Chemistry, 2024, 269, 116352.

Salesse L, Duval A, Sauvanet P, Da Silva A, Barnich N, Godfraind C, Dalmasso G, Nguyen HTT. ATG16L1 in myeloid cells limits colorectal tumor growth in ApcMin/+ mice infected with colibactin-producing Escherichia coli via decreasing inflammasome activation.Autophagy. 2024 Jun 10:1-19. doi: 10.1080/15548627.2024.2359770. Online ahead of print. PMID: 38818900

Gilbert G, Renaud Y, Teste C, Anglaret N, Bertrand R, Hoehn S, Jurkowski TP, Schuettengruber B, Cavalli G, Waltzer L, Vandel L. Drosophila TET acts with PRC1 to activate gene expression independently of its catalytic activity. Sci Adv. 2024 May 3;10(18):eadn5861. doi: 10.1126/sciadv.adn5861. Epub 2024 May 3. PMID: 38701218; PMCID: PMC11068012.